BioCorRx Inc.
corporate_fare Company Profile
BioCorRx Inc. (OTC:BICX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 5 items for BICX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 5 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for BICX spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- BioCorRx Q3: Cash Down to $18,233, Going Concern Doubt Reaffirmed
- BioCorRx Q2 2026: Going Concern Warning, Revenue Halved, Cash Down to $21K
- BioCorRx Reports Q1 2026 Results: Revenue Up 59%, Cash Burn Improves Amidst Ongoing Going Concern
- BioCorRx Issues 2.26M Shares to Insiders for Full Subsidiary Control, Diluting Shareholders
- BioCorRx Reports Going Concern, Revenue Surge from Lucemyra Acquisition, and Insider Stock Purchase
Financial Snapshot
Short Interest & Short Volume
22.20 days to coverFINRA reported short interest of 9,903 shares in BICX as of the October 30, 2026 settlement, a 0.2% decrease from the prior period — about 22.2 days to cover at its recent average daily volume. On November 19, 2026, 100.0% of BICX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.